|
Bacterial isolates (n)
| |
Antimicrobial agents
|
|---|
|
Pattern
|
ERY
|
CD
|
GEN
|
P
|
CXT
|
TE
|
DOX
|
CIP
|
COT
|
CFP
|
VAN
|
AMP
|
|---|
|
CoNS (44)
|
S
|
17 (38.6)
|
28 (63.6)
|
29 (65.9)
|
14 (31.8)
|
22 (50)
|
22 (50)
|
28 (63.6)
|
22 (50)
|
10 (22.7)
|
ND
|
ND
|
ND
|
|
NS
|
27 (61.4)
|
16 (36.4)
|
15 (34.1)
|
30 (68.2)
|
22 (50)
|
22 (50)
|
16 (36.4)
|
22 (50)
|
34 (77.3)
|
ND
|
ND
|
ND
|
|
S. aureus (15)
|
S
|
7 (46.7)
|
7 (46.7)
|
8 (53.3)
|
4 (26.7)
|
2 (13.3)
|
6 (40)
|
6 (40)
|
9 (60)
|
8 (53.3)
|
ND
|
ND
|
ND
|
|
NS
|
8 (53.3)
|
8 (53.3)
|
7 (46.7)
|
11(73.3)
|
13 (86.7)
|
9 (60)
|
9 (60)
|
6 (40)
|
7 (46.7)
|
ND
|
ND
|
ND
|
|
Enterococcus species (9)
|
S
|
ND
|
ND
|
6 (66.7)
|
4 (44.4)
|
ND
|
ND
|
ND
|
ND
|
ND
|
ND
|
6 (66.7)
|
7 (77.8)
|
|
NS
|
ND
|
ND
|
3 (33.3)
|
5 (55.6)
|
ND
|
ND
|
ND
|
ND
|
ND
|
ND
|
3 (33.3)
|
2 (22.2)
|
|
Viridans streptococci (3)
|
S
|
1 (33.3)
|
1 (33.3)
|
ND
|
ND
|
ND
|
1 (33.3)
|
ND
|
ND
|
ND
|
1 (33.3)
|
1 (33.3)
|
ND
|
|
NS
|
2 (66.7)
|
2 (66.7)
|
ND
|
ND
|
ND
|
2 (66.7)
|
ND
|
ND
|
ND
|
2 (66.7)
|
2 (66.7)
|
ND
|
|
S. pyogenes (2)
|
S
|
2 (100)
|
0
|
ND
|
0
|
ND
|
0
|
ND
|
ND
|
ND
|
0
|
0
|
ND
|
|
NS
|
0
|
2 (100)
|
ND
|
2 (100)
|
ND
|
2 (100)
|
ND
|
ND
|
ND
|
2 (100)
|
2 (100)
|
ND
|
|
Total (73)
|
S
|
27 (42.2)
|
36 (56.3)
|
43 (63.2)
|
22 (32.4)
|
24 (40.7)
|
29 (46.8)
|
34 (57.6)
|
31 (52.5)
|
18 (30.5)
|
1 (20)
|
ND
|
7 (77.8)
|
|
NS
|
37 (57.8)
|
28 (43.7)
|
25 (36.8)
|
46 (67.6)
|
35 (59.3)
|
33 (53.2)
|
25 (42.4)
|
28 (47.5)
|
41 (67.8)
|
4 (80)
|
ND
|
2 (22.2)
|
- AST antimicrobial susceptibility test, CoNS coagulase negative Staphylococci, ERY erythromycin, CD clindamycin, GEN gentamicin, PEN penicillin, CXT cefoxitin, TE tetracycline, DOX doxycycline, CIP ciprofloxacin, COT cotrimoxazole, CFP cefepime, VAN vancomycin, AMP ampicillin, ND susceptibility test not done, S susceptible, NS non-susceptible
